1024 related articles for article (PubMed ID: 33785743)
1. Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial.
Jagannathan P; Andrews JR; Bonilla H; Hedlin H; Jacobson KB; Balasubramanian V; Purington N; Kamble S; de Vries CR; Quintero O; Feng K; Ley C; Winslow D; Newberry J; Edwards K; Hislop C; Choong I; Maldonado Y; Glenn J; Bhatt A; Blish C; Wang T; Khosla C; Pinsky BA; Desai M; Parsonnet J; Singh U
Nat Commun; 2021 Mar; 12(1):1967. PubMed ID: 33785743
[TBL] [Abstract][Full Text] [Related]
2. Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial.
Feld JJ; Kandel C; Biondi MJ; Kozak RA; Zahoor MA; Lemieux C; Borgia SM; Boggild AK; Powis J; McCready J; Tan DHS; Chan T; Coburn B; Kumar D; Humar A; Chan A; O'Neil B; Noureldin S; Booth J; Hong R; Smookler D; Aleyadeh W; Patel A; Barber B; Casey J; Hiebert R; Mistry H; Choong I; Hislop C; Santer DM; Lorne Tyrrell D; Glenn JS; Gehring AJ; Janssen HLA; Hansen BE
Lancet Respir Med; 2021 May; 9(5):498-510. PubMed ID: 33556319
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding, and Duration of Symptoms Among Patients With Mild to Moderate COVID-19: A Phase 2 Randomized Clinical Trial.
Cairns DM; Dulko D; Griffiths JK; Golan Y; Cohen T; Trinquart L; Price LL; Beaulac KR; Selker HP
JAMA Netw Open; 2022 Feb; 5(2):e2144942. PubMed ID: 35138402
[TBL] [Abstract][Full Text] [Related]
4. Early Treatment with Pegylated Interferon Lambda for Covid-19.
Reis G; Moreira Silva EAS; Medeiros Silva DC; Thabane L; Campos VHS; Ferreira TS; Santos CVQ; Nogueira AMR; Almeida APFG; Savassi LCM; Figueiredo-Neto AD; Dias ACF; Freire Júnior AM; Bitarães C; Milagres AC; Callegari ED; Simplicio MIC; Ribeiro LB; Oliveira R; Harari O; Wilson LA; Forrest JI; Ruton H; Sprague S; McKay P; Guo CM; Limbrick-Oldfield EH; Kanters S; Guyatt GH; Rayner CR; Kandel C; Biondi MJ; Kozak R; Hansen B; Zahoor MA; Arora P; Hislop C; Choong I; Feld JJ; Mills EJ; Glenn JS;
N Engl J Med; 2023 Feb; 388(6):518-528. PubMed ID: 36780676
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory but not respiratory symptoms are associated with ongoing upper airway viral shedding in outpatients with uncomplicated COVID-19.
Jacobson KB; Purington N; Parsonnet J; Andrews J; Balasubramanian V; Bonilla H; Edwards K; Desai M; Singh U; Hedlin H; Jagannathan P
Diagn Microbiol Infect Dis; 2022 Mar; 102(3):115612. PubMed ID: 34974350
[TBL] [Abstract][Full Text] [Related]
6. Favipiravir for Treatment of Outpatients With Asymptomatic or Uncomplicated Coronavirus Disease 2019: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial.
Holubar M; Subramanian A; Purington N; Hedlin H; Bunning B; Walter KS; Bonilla H; Boumis A; Chen M; Clinton K; Dewhurst L; Epstein C; Jagannathan P; Kaszynski RH; Panu L; Parsonnet J; Ponder EL; Quintero O; Sefton E; Singh U; Soberanis L; Truong H; Andrews JR; Desai M; Khosla C; Maldonado Y
Clin Infect Dis; 2022 Nov; 75(11):1883-1892. PubMed ID: 35446944
[TBL] [Abstract][Full Text] [Related]
7. Ivermectin for preventing and treating COVID-19.
Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
[TBL] [Abstract][Full Text] [Related]
8. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
[TBL] [Abstract][Full Text] [Related]
9. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
[TBL] [Abstract][Full Text] [Related]
10. Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study.
He XL; Zhou YY; Fu W; Xue YE; Liang MY; Yang BH; Ma WL; Zhou Q; Chen L; Zhang JC; Wang XR
Curr Med Sci; 2021 Dec; 41(6):1096-1104. PubMed ID: 34515914
[TBL] [Abstract][Full Text] [Related]
11. Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B).
Chan HLY; Ahn SH; Chang TT; Peng CY; Wong D; Coffin CS; Lim SG; Chen PJ; Janssen HLA; Marcellin P; Serfaty L; Zeuzem S; Cohen D; Critelli L; Xu D; Wind-Rotolo M; Cooney E;
J Hepatol; 2016 May; 64(5):1011-1019. PubMed ID: 26739688
[TBL] [Abstract][Full Text] [Related]
12. Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
Gottlieb RL; Nirula A; Chen P; Boscia J; Heller B; Morris J; Huhn G; Cardona J; Mocherla B; Stosor V; Shawa I; Kumar P; Adams AC; Van Naarden J; Custer KL; Durante M; Oakley G; Schade AE; Holzer TR; Ebert PJ; Higgs RE; Kallewaard NL; Sabo J; Patel DR; Klekotka P; Shen L; Skovronsky DM
JAMA; 2021 Feb; 325(7):632-644. PubMed ID: 33475701
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Hosseini FS; Malektojari A; Ghazizadeh S; Hassaniazad M; Davoodian P; Dadvand H; Nikpoor AR; Nikoofal-Sahlabadi S; Kahoori S; Sepandi M; Hassanipour S; Fathalipour M
Trials; 2021 Jan; 22(1):4. PubMed ID: 33397429
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Acebilustat, a Selective Inhibitor of Leukotriene B4 Biosynthesis, for Treatment of Outpatients With Mild-Moderate Coronavirus Disease 2019: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
Levitt JE; Hedlin H; Duong S; Lu D; Lee J; Bunning B; Elkarra N; Pinsky BA; Heffernan E; Springman E; Moss RB; Bonilla HF; Parsonnet J; Zamanian RT; Langguth JJ; Bollyky J; Khosla C; Nicolls MR; Desai M; Rogers AJ
Clin Infect Dis; 2023 Jul; 77(2):186-193. PubMed ID: 36996150
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics of peginterferon lambda-1a following single dose administration to subjects with impaired renal function.
Hruska MW; Adamczyk R; Colston E; Hesney M; Stonier M; Myler H; Bertz R
Br J Clin Pharmacol; 2015 Sep; 80(3):515-24. PubMed ID: 25807956
[TBL] [Abstract][Full Text] [Related]
17. A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C.
Flisiak R; Shiffman M; Arenas J; Cheinquer H; Nikitin I; Dong Y; Rana K; Srinivasan S
PLoS One; 2016; 11(10):e0164563. PubMed ID: 27749900
[TBL] [Abstract][Full Text] [Related]
18. Lopinavir/ritonavir and interferon combination therapy may help shorten the duration of viral shedding in patients with COVID-19: A retrospective study in two designated hospitals in Anhui, China.
Zuo Y; Liu Y; Zhong Q; Zhang K; Xu Y; Wang Z
J Med Virol; 2020 Nov; 92(11):2666-2674. PubMed ID: 32492211
[TBL] [Abstract][Full Text] [Related]
19. Peginterferon Lambda-1a/Ribavirin with Daclatasvir or Peginterferon Alfa-2a/Ribavirin with Telaprevir for Chronic Hepatitis C Genotype 1b.
Flisiak R; Kawazoe S; Znoyko O; Assy N; Gadano A; Kao JH; Lee KS; Zwirtes R; Portsmouth S; Dong Y; Xu D; Kumada H; Srinivasan S
J Interferon Cytokine Res; 2016 Nov; 36(11):635-643. PubMed ID: 27327078
[TBL] [Abstract][Full Text] [Related]
20. Peginterferon lambda for the treatment of hospitalized patients with mild COVID-19: A pilot phase 2 randomized placebo-controlled trial.
Kim MH; Elbaz J; Jilg N; Gustafson JL; Xu M; Hatipoglu D; Nohelty E; Kim AY; Chung RT
Front Med (Lausanne); 2023; 10():1095828. PubMed ID: 36910479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
